These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24697759)

  • 1. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
    Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
    Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
    Otrock ZK; Sempek DS; Carey S; Grossman BJ
    Transfusion; 2017 Jun; 57(6):1522-1526. PubMed ID: 28301051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
    Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Minakawa K; Tanosaki R
    Transfusion; 2020 May; 60(5):1015-1023. PubMed ID: 32306410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical side effects during peripheral blood progenitor cell infusion.
    Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
    Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of hematopoietic cell infusion in children with malignant and non-malignant diseases.
    Heneghan C; Smilow E; Tanhehco Y; Jin Z; Cofnas P; Schwartz S; Patel N; Carberry D; Silverman J; Huynh P; Hagan B; Tobin K; Bhatia M; George D; Garvin J; Satwani P
    Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28845921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
    Padley DJ; Dietz AB; Gastineau DA
    Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system.
    Zinno F; Landi F; Scerpa MC; Aureli V; Lanti A; Ceccarelli S; Caniglia M; Miele MJ; Daniele N; Landolfo A; Cometa AM; Locatelli F; Isacchi G
    Transfusion; 2011 Dec; 51(12):2656-63. PubMed ID: 21599671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
    Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
    Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.
    Eisenberg S; Wickline M; Linenberger M; Gooley T; Holmberg L
    Oncol Nurs Forum; 2013 May; 40(3):285-92. PubMed ID: 23615140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a -80°C mechanical freezer and preserved less than 6 months.
    Calvet L; Cabrespine A; Boiret-Dupré N; Merlin E; Paillard C; Berger M; Bay JO; Tournilhac O; Halle P
    Transfusion; 2013 Mar; 53(3):570-8. PubMed ID: 22804351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
    Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
    Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient care during infusion of hematopoietic progenitor cells.
    Sauer-Heilborn A; Kadidlo D; McCullough J
    Transfusion; 2004 Jun; 44(6):907-16. PubMed ID: 15157259
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions during transfusion of thawed haematopoietic progenitor cells from apheresis are closely related to the number of granulocyte cells in the leukapheresis product.
    Martín-Henao GA; Resano PM; Villegas JM; Manero PP; Sánchez JM; Bosch MP; Codins AE; Bruguera MS; Infante LR; Oyarzabal AP; Soldevila RN; Caiz DC; Bosch LM; Barbeta EC; Ronda JR
    Vox Sang; 2010 Oct; 99(3):267-73. PubMed ID: 20840341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.